Journal Logo

Eliezer Rachmilewitz (1935–2017)

Cabantchik, Ioav1; Muckenthaler, Martina2; Camaschella, Clara3

doi: 10.1097/HS9.0000000000000021
HemaTopics
Open

1Hebrew University of Jerusalem, Jerusalem, Israel

2University Hospital Heidelberg, Heidelberg, Germany

3San Raffaele Scientific Institute, Milan, Italy

Correspondence: Martina Muckenthaler (e-mail: Martina.Muckenthaler@med.uni-heidelberg.de).

Citation: Cabantchik I, Muckenthaler M, Camaschella C. Eliezer Rachmilewitz (1935–2017). HemaSphere, 2018;2:1. http://dx.doi.org/10.1097/HS9.0000000000000021

Funding/support: None.

The authors have indicated they have no potential conflicts of interest to disclose.

This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0

Eliezer Rachmilewitz (1935–2017).

Eliezer Rachmilewitz (1935–2017).

The hematology community mourns the sudden death of Professor Eliezer Rachmilewitz, who passed away on December 17, 2017. Spending most of his career in the Hadassah Medical Center in Jerusalem, Eliezer was one of the pioneers of thalassemia research, and one of the first to recognize the relationship between oxidative stress and iron overload in a variety of hematological disorders. He had a passion for medical research and until the last moments of his life he shared it with colleagues and students. He always showed an incredible learning ability and enthusiasm for new developments in basic and clinical research. Eliezer had an outgoing personality with a flair for approaching and attracting people and offering his professional assistance to those in need. He was endowed with a special skill for liaising between investigators specializing in different areas of biomedicine and, as such, he generated fruitful collaborations with numerous people worldwide, including those in Israel, the Palestinian territories, and Arab countries.

Eliezer was the son of one of the legendary scholars and physicians who founded the Hadassah Medical Center in Israel as both and academic and clinical institution of worldwide reputation, and he continued that tradition of excellence until very recently. Eliezer will undoubtedly be missed by his family and by the extended biomedical community.

Copyright © 2018 The Authors. Published by Wolters Kluwer Health Inc., on behalf of the European Hematology Association.